Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Joint analysis of BICEP2/keck array and Planck Data.

Physical review letters·2015
Same author

Rapid identification of Clostridium botulinum colonies by in vitro toxicity and antimicrobial susceptibility testing.

World journal of microbiology & biotechnology·2014
Same author

Clostridium difficile infection.

Current problems in surgery·2013
Same author

Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC.

Journal of chemotherapy (Florence, Italy)·2004
Same author

Complications of HIV therapy.

The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2002
Same author

Update on opportunistic infections.

The Hopkins HIV report : a bimonthly newsletter for healthcare providers·2002

Related Experiment Video

Updated: Jul 13, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Report on new drugs

J G Bartlett

    The Hopkins HIV Report : a Bimonthly Newsletter for Healthcare Providers
    |August 20, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
    07:39

    SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

    Published on: June 28, 2019

    Cost-Efficient Transcriptomic-Based Drug Screening
    06:40

    Cost-Efficient Transcriptomic-Based Drug Screening

    Published on: February 23, 2024

    Related Experiment Videos

    Last Updated: Jul 13, 2026

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
    07:39

    SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs

    Published on: June 28, 2019

    Cost-Efficient Transcriptomic-Based Drug Screening
    06:40

    Cost-Efficient Transcriptomic-Based Drug Screening

    Published on: February 23, 2024